REDUCTION OF EXYL-1-[(1R)-1,2-DIPHENYLETHYL]-PIPERAZINE-INDUCED MEMORY IMPAIRMENT OF PASSIVE-AVOIDANCE PERFORMANCE BY SIGMA(1) RECEPTOR AGONISTS IN MICE
K. Matsuno et al., REDUCTION OF EXYL-1-[(1R)-1,2-DIPHENYLETHYL]-PIPERAZINE-INDUCED MEMORY IMPAIRMENT OF PASSIVE-AVOIDANCE PERFORMANCE BY SIGMA(1) RECEPTOR AGONISTS IN MICE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 575-580
Intraperitoneal administration of 4-cyclohexyl-1-[1R)-1,2-diphenylethy
l]-piperazine (CDEP) immediately after the training session produced s
ignificant memory impairment in the mouse passive avoidance performanc
e. Interestingly this memory impairment was alleviated by subcutaneous
administrations of sigma receptor agonists, (+)-N-allylnormetazocine
((+)-SKF-10,047) (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ((+)-3
-PPP) and 1,3-di(2-tolyl)guanidine (DTG) immediately after the trainin
g session. In particular, the remarked recovery for this memory impair
ment was produced by (+)-SKF-10,047. A receptor binding study showed t
hat CDEP possessed high affinities for both sigma(1) and sigma(2) rece
ptor subtypes (IC50 1.4 +/- 0.3 nM for sigma(1) receptor subtype, 1.8
+/- 0.3 nM for sigma(2) receptor subtype), while (+)-SKF-10,047 had a
high selectivity for the sigma(1) receptor subtype. These findings sug
gest that the sigma receptor; particularly sigma(1) receptor subtype,
may play an important role in the CDEP-induced impairment of learning
and memory processes. (C) 1998 Prous Science. All rights reserved.